Wuhan Landing Intelligence Medical Co., Ltd.

Company News

Chinese Medtech Company Landing Med Surpasses 10 Million AI-Assisted Pap Smear Screenings
19
Jan
2024
Landing Med, a Chinese medtech company focused on early cancer detection, has achieved a significant milestone by completing over 10 million cervical cancer screenings using artificial intelligence (AI). Established by Dr. Xiaorong Sun, the company has been integrating automation, digital, AI, and cloud computing technologies into Pap smear testing across China since 2017.
Learn More
China to Provide Technology for Cervical Cancer Screening
21
Nov
2023
ISLAMABAD: A hospital of federal capital has joined hands with Landing Med, medical technology company, based in Wuhan China, to make use of the artificial intelligence (AI) in advancing cervical cancer screening.
Learn More
ANTH, Landing Med introducing AI-based screening for Cervical Cancer in Pakistan
20
Nov
2023
Islamabad:In a landmark move towards improving cancer care, Dr. Akbar Niazi Teaching Hospital (ANTH) in Islamabad, Pakistan, has joined forces with Landing Med, medical technology company based in Wuhan, China, to make use of the Artificial Intelligence (AI) in advancing Cervical Cancer screening, says a press release.
Learn More